Ferring GmbH (manufacturer of the finished product, responsible for primary packaging, quality control and batch release)
UkraineAll drugs from this manufacturer
-
The drug is intended for the treatment of adult men with advanced hormone-sensitive prostate cancer.
Dosage form: powder for injection solution
Active substance Dosage degarelix 80 mg ATC: L02BX02
-
The drug is intended for the treatment of adult men with advanced hormone-sensitive prostate cancer.
Dosage form: powder for injection solution
Active substance Dosage degarelix 120 mg ATC: L02BX02
-
The drug is used for emergency assistance in bleeding from esophageal varices, as well as for adjuvant therapy in combination with endoscopic methods and to reduce the risk of rebleeding.
Dosage form: powder for injection solution
Active substance Dosage terlipressin 1 mg ATC: H01BA04